COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,398 Articles (22,816 medRxiv, 8,582 bioRxiv)

Most recent first Previous |  Page 2259: Articles 22581-22590  | Next

Knowledge, attitudes and practices associated with the COVID-19 among slum dwellers resided in Dhaka City: A Bangladeshi interview-based survey
Islam, M. S., Emran, M. G. I., Rahman, M. E., Banik, R., Sikder, M. T., Smith, L., Hossain, S.
10.1101/2020.09.15.20195255 — Posted: 2020-09-18
COVID-19 incidence and mortality in the Metropolitan Region, Chile: time, space, and structural factors
Villalobos Dintrans, P., Castillo, C., de la Fuente, F., Maddaleno, M.
10.1101/2020.09.15.20194951 — Posted: 2020-09-18
Association among income loss, financial strain and depressive symptoms during COVID-19: evidence from two longitudinal studies
Hertz-Palmor, N., Moore, T. M., Gothelf, D., DiDomenico, G. E., Dekel, I., Greenberg, D. M., Brown, L. A., Matalon, N., Visoki, E., White, L. K., Himes, M. H., Lifshitz-Schwartz, M., Gross, R., Gur, R. C., Gur, R. E., Pessach, I. M., Barzilay, R.
10.1101/2020.09.15.20195339 — Posted: 2020-09-18
A SARS-CoV-2 Reference Standard Quantified by Multi-digital PCR Platforms for Quality Assessment of Molecular Tests
Zhou, H., Liu, D., Ma, L., Ma, T., Xu, T., Ren, L., Li, L., Xu, S.
10.1101/2020.09.14.20193904 — Posted: 2020-09-18
Prediction of Covid-19 Infections Through December 2020 for 10 US States Incorporating Outdoor Temperature and School Re-Opening Effects-August Update
Newell, T. A.
10.1101/2020.09.14.20193821 — Posted: 2020-09-18
Antibodies to SARS-CoV-2 and risk of future sickness
Dillner, J., Elfström, M., Blomqvist, J., Eklund, C., Lagheden, C., Nordqvist-Kleppe, S., Hellström, C., Olofsson, J., Andersson, E., Jernbom Falk, A., Bergström, S., Hultin, E., Pin, E., Manberg, A., Nilsson, P., Hedhammar, M., Hober, S., Mattsson, J., Arroyo Mühr, L. S., Conneryd Lundgren, K.
10.1101/2020.09.14.20194308 — Posted: 2020-09-18 Discussion: Offsite
Improved estimation of time-varying reproduction numbers at low case incidence and between epidemic waves
Parag, K. V.
10.1101/2020.09.14.20194589 — Posted: 2020-09-18
COVID-19 epidemic severity is associated with timing of non-pharmaceutical interventions
Ragonnet-Cronin, M., Boyd, O., Geidelberg, L., Jorgensen, D., Nascimento, F. F., Siveroni, I., Johnson, R., Baguelin, M., Cucunuba, Z. M., Jauneikaite, E., Mishra, S., Thompson, H. A., Watson, O. J., Ferguson, N., Donnelly, C. A., Volz, E.
10.1101/2020.09.15.20194258 — Posted: 2020-09-18
Longitudinal analysis of the utility of liver biochemistry in hospitalised COVID-19 patients as prognostic markers
Wang, T., Smith, D. A., Campbell, C., Harris, S., Salih, H., Varnai, K. A., Woods, K., Noble, T., Freeman, O., Moysova, Z., Marjot, T., Webb, G. J., Davies, J., Barnes, E., Matthews, P. C.
10.1101/2020.09.15.20194985 — Posted: 2020-09-18
Distribution equality as an optimal epidemic mitigation strategy
Hacohen, A., Cohen, R., Efroni, S., Bachelet, I., Barzel, B.
10.1101/2020.09.15.20194506 — Posted: 2020-09-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).